Essra Ridha - 08 Feb 2023 Form 4 Insider Report for AVROBIO, Inc. (TECX)

Role
Chief Medical Officer
Signature
/s/ Steven Avruch, Attorney in Fact for Essra Ridha
Issuer symbol
TECX
Transactions as of
08 Feb 2023
Net transactions value
$0
Form type
4
Filing time
10 Feb 2023, 16:14:15 UTC
Previous filing
09 Dec 2022
Next filing
05 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVRO Restricted Stock Unit Award $0 +131,333 $0.000000 131,333 08 Feb 2023 Common Stock 131,333 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the RSU shall vest over 4 years, with 25% vesting annually on each anniversary of the Vesting Commencement Date of February 1, 2023.